
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
REVIEW
miRNA biogenesis and functioning: 30 years since their discovery
1 Chazov National Medical Research Center of Cardiology, Moscow, Russia
2 Pirogov Russian National Research Medical University
Correspondence should be addressed: Maria V. Pisklova
Akademika Chazova, 15А, Moscow, 121552, Russia; ur.liam@airam_avolksip
Funding: the study was conducted within the framework of the State Assignment of the Chazov National Medical Research Center of Cardiology (No. 124020200013-3).
Author contribution: Pisklova MV — literature data acquisition, analysis and systematization, planning and writing the manuscript draft, selecting drawings; Baulina NM, Favorova OO — planning, manuscript structuring, editing; Matveeva NA — literature data analysis and systematization, manuscript writing.
The role of miRNAs (small non-coding RNAs) in regulation of gene expression is reported. By binding with target mRNAs miRNAs control expression of the genes encoding these mRNAs at post-transcriptional level taking part in physiological and pathological processes, from embryogenesis to neoplastic disorders. Various research teams have been studying the miRNA functions and mechanisms of action since the discovery of these molecules in 1993. The paper reports miRNA biogenesis pathways, modes of interaction between miRNAs and target mRNAs, and the mechanisms underlying suppression of translation and mRNA degradation. The results of numerous studies have shown that miRNAs can be used in medicine as biomarkers for diagnostic and prognostic purposes. Developments in miRNA therapeutics hold promise for the treatment of diseases, in which gene dysregulation plays a key role.
Keywords: diagnostics, miRNA, therapy, regulation of gene expression, miRNA biogenesis, prognosis of disease progression